His gift for ready invention was further amplified during his fruitful career at the National Institutes of Health (1975 Health ( -1992 when the US-patents listed in Table I were issued to him as inventor or co-inventor. Brossi's great achievement is his reliance on the great Ziirich tradition for natural products in carrying it forward to the frontier of modern medicine, so that progress is based on tradition not only preserved but revitalized. His research reminds us all that the plant kingdom must still hold in reserve many potential drugs that are awaiting discovery. Long before chirality emerged as a key issue in pharmaceutical research [cf. Stu Borman, Chemical & Engineering News, July 9, p. 10 (1990) l and led to a wave of new enantiomeric chiral drugs [cf. Chemical & Engineering News, September 27, p. 38 -65 (1993) 1. Arnold Brossi preached his gospel for chiral purity and became a pioneer for chirotechnology by the conversion of academic asymmetric syntheses and resolutions of racemates into procedures that are commercially feasible. He joined an animated discussion with Ernest Eliel [cf. Chemical & Engineering News, July 22 (1991) whether a chiral compound is racemic or "aracemic","eutomeric" or "distomeric" by preferring the terms "enantio-enriched" and "enantio-pure". Brossi's contributions to medicinal agents, ranging from amebicides and antimalarials to antidepressants and potential curatives for cognitive disorders, such as Alzheimer disease, are summarized in Table II , his major research activities in Table Ill . His lifelong attachment to alkaloids deserves special mention and consideration, because he not only preserved and continued a great tradition as Editor of "THE ALKALOIDS", Volume 21-40, but breathed new life into old structures: Table IV . When 6-hydroxydopamine was suspected as a possibly endogenous biogenic amine damaging adrenergic nerve terminals, Brossi synthesized the parent amino acid (Table  V) which many years later surfaced as a new natural amino acid at the active site of bovine serum amine oxidase [Science, 248, 981 -987 (1990) 23. 1-70, 1984 and ibid., 41, 125-172. 19921; Physostigmine [351, 3691; Mammalian Alkaloids [362, The Alkaloids, 43, 11 9 -183, 
19931.
Brossi was editor-in-chief of Org. Synthesis Vol. 53 and is now on its Advisory Board.
As is already mentioned, he was from 1983 -1991 editor-in-chief of The Alkaloids and has Volumes 21 -40 to his crtedit, sharing with G. A. Cordell co-editorship for Volumes 41 and 44 (in press). Under Brossi the term alkaloid was used more lucidly, allowing him to include nitrogen-containing substances from marine organisms and from mammals. He insisted that biological data when available be reported. Brossi, for keeping this book series alive, was in 1991 awarded Honorary Membership in the American Society of While the artist's communication is linked forever with its original form, that of the scientist is modified, amplified and fused with the ideas and results of others and melts into the stream of knowledge and ideas which contribute to man's benefit and progress. The first forty years in a man's life form the text; the next thirty years are commentary. At age seventy our friend Arnold is a well-commented text with room for expansion in many promising directions.
TABLE 1 PATENTS
Brossi is named as an inventor and co-inventor on many patents which were issued during his association with Hoffmann-La Roche (1952 -1975 The introduction of Versidyne, a combination of methophoiine with aspirin, was stopped because of unexpected toxicity seen in dogs, but later found not to be drug related. " Arteether, an analog of artemether which is used in China as an antimalarial drug, is presently undergoing clinical trials.
... Phenserine, the most effective agent to treat cognitive disorders, is scheduled for chronic toxicity. [ I ,20,25,55,57,65,37,70] 344, 362, 381, 388, 3891 . This work includes the first synthesis of optically active 1-methyl-and 1-benzyl-6,7-dihydroxytetrahydro-isoquinoline-1-carboxylic acids [294] , and signaled that norreticuline could be a precursor of mammalian morphine [381] . [6,7,3,14,15,104.153,156,159, This work includes an improved synthesis of unnatural (+)-morphine [159], a synthesis of 3-deoxymorphine and dihydro-congeners [167], a total synthesis of (?)-4-hydroxy-Nmethylmorphinan-6-one 1217, (-)-2-hydroxy-N-methyl-morphinan-6-one [216], (-)-Ihydroxy-N-methyl-morphinan-6-one [222] , and a total synthesis of (*)-3-deoxydihydromorphine [231] . 5. COLCHlClNOlDS AND I 80, 182, 190, 191, 192, 196, 199, 226, 229, 230, 245, 256, 261, 262, 269, 276, 283, 285, 289, 298, 304, 334, 339, 324, 322, 341, 345, 350.351, 356, 358, 367, 368, 369, 371, 372, 326, 339, 377, 378, 382, 386, 255] . This work includes a revision of the structures of epoxycolchicine (1821, and that of cornigerine [199] . It also includes a simple conversion of colchicine into demecolcine [172] , a synthesis of colchifoline (1921 and improved procedures to prepare 2-and 3-demethylcolchicine [196] , and of unnatural (+)-cochicine [196, 276] [275,277,280,293.305,311,313,314,319,323,328,329,343,351,374, 375.379.380.383,385] . This work includes a novel route to optically active amines by fragmentation of urea precursors in high boiling alcohols [277] . The morphine-like activity of (-)-eseroline was substantiated [280] . An easy conversion of physostigmine into (-)-eseroline was reported [293] and the structure of genserine was clarified [328] . A simple synthesis of natural physovenine was reported [343.361] . Phenylcarbamate analogs of physostigmine were recognized as valuable agents to treat cognitive disorders [374, 3751. [123,127,133,134,286.290 ].
MORPHINANS AND MORPHINE-ALKALOIDS
- The antimalarial arteether derived from artmisinin is now undergoing a clinical evaluation [303] . Both enantiomers of dihjydroquinine were equally effective antimalarials when tested in Plasmodium berghei infection in mice [129] . The absolute configuration of (+)-primaquine was determined to be (S) [291] .
